Science-backed digital program addressing chronic kidney disease through gut microbiome restoration, dietary modification, and kidney tissue support across three structured phases, distributed via ClickBank with a 60-day satisfaction guarantee
The Chronic Kidney Disease Solution, a three-phase digital program by Shelly Manning addressing CKD through gut health restoration, blood glucose stabilization, and kidney tissue repair, with lifetime digital access and no recurring costs.
BOISE, Idaho, August 1, 2026 — Blue Heron Health News today announced the commercial availability of The Chronic Kidney Disease Solution, a three-phase digital health program authored by Shelly Manning, distributed via ClickBank, and backed by a 60-day satisfaction guarantee. The program is available for direct purchase through the company’s authorized retail portal at blueheronhealthnews.com and is delivered as a digital PDF/e-book with lifetime access and unlimited downloads.
The Chronic Kidney Disease Solution is a structured lifestyle and dietary intervention program designed for individuals managing chronic kidney disease. Its three-phase approach progresses from protecting remaining kidney function through gut health restoration and blood glucose stabilization, through restoring kidney function via dietary modification, to supporting kidney and heart tissue repair using specific foods and natural supplements. The program is grounded in peer-reviewed research on the gut-kidney axis, the role of gut microbiome health in systemic disease, and the relationship between lifestyle factors and CKD progression. The program is available as a digital PDF and includes an optional physical book edition at cost of printing only.
Product Overview
The Chronic Kidney Disease Solution is a digital health program authored by Shelly Manning of Blue Heron Health News. The company states that the program was developed to provide CKD sufferers with a structured, evidence-informed approach to addressing the underlying causes of chronic kidney disease — particularly gut microbiome imbalance, immune system dysregulation, and systemic inflammation — through targeted lifestyle and dietary modification. The program does not claim to replace medical treatment, and the author specifically advises readers to continue working with their healthcare provider throughout the program.
The program is authored by Shelly Manning, a natural health practitioner with extensive experience working with individuals affected by chronic kidney disease and associated conditions. The program content is supported by peer-reviewed research from recognized scientific institutions on the gut-kidney axis, microbiome health, and dietary intervention in CKD. All scientific references cited in this press release describe independent research conducted under conditions unaffiliated with Blue Heron Health News.
“The Chronic Kidney Disease Solution was developed to give CKD sufferers a clear, step-by-step framework for addressing the lifestyle and dietary factors that drive kidney disease progression. The program is grounded in peer-reviewed research on the gut-kidney connection and systemic inflammation. We do not claim that the program replicates the outcomes of the studies cited within it, which were conducted independently and under conditions unaffiliated with Blue Heron Health News. Readers are encouraged to continue working with their healthcare provider throughout their CKD journey.”
— Shelly Manning, Author, The Chronic Kidney Disease Solution / Blue Heron Health News
Program Content Overview
The following section describes the three phases comprising The Chronic Kidney Disease Solution, as disclosed by the author. Each phase description is accompanied by independent published research on the specific mechanism or intervention addressed in that phase. These citations describe research conducted under conditions unaffiliated with Blue Heron Health News and do not constitute clinical evidence that this program produces equivalent outcomes to those described in the cited studies.
Phase 1 — Protect from Kidney Damage. Phase 1 focuses on halting further kidney damage by making targeted adjustments to daily dietary and lifestyle habits. The phase addresses gut microbiome restoration as a primary mechanism, based on the established relationship between gut health, immune system function, and systemic inflammation in CKD progression. Phase 1 also directly addresses blood glucose balancing through dietary modification — not caloric restriction — to reduce the metabolic burden on damaged kidneys. Research published in Journal of the American Society of Nephrology (Evenepoel, P., et al., 2017, “The gut-kidney axis,” doi:10.1681/ASN.2017030268) examined the bidirectional relationship between gut microbiome health, intestinal barrier function, and kidney disease progression in adult subjects, establishing the gut-kidney axis as a clinically relevant pathway in CKD management. The study was conducted independently and was not affiliated with Blue Heron Health News.
Phase 2 — Restore Kidney Function. Phase 2 builds on the gut health restoration initiated in Phase 1, focusing on establishing stable blood glucose levels for the long term, continuing microbiome recovery, and supporting gradual restoration of kidney filtration function as metabolic stressors are reduced. The author notes that many readers experience measurable improvements in energy, mood, and weight normalization during this phase despite no caloric restriction. Research published in Nephrology Dialysis Transplantation (Vaziri, N.D., et al., 2013, “Chronic kidney disease alters intestinal microbial flora,” doi:10.1093/ndt/gfs497) examined the bidirectional relationship between chronic kidney disease and intestinal microbiota composition in adult subjects, demonstrating that CKD significantly alters gut bacterial populations and that restoration of microbiome balance is relevant to kidney function outcomes. The study was conducted independently and was not affiliated with Blue Heron Health News.
Phase 3 — Repair and Renew Kidney Tissue. Phase 3 addresses kidney and heart tissue repair using specific dietary interventions and natural supplements available from standard retail sources. The author describes using these approaches to support new stem cell generation for kidney and heart tissue renewal, alongside the normalization of blood pressure that had previously contributed to kidney damage. The phase represents the culmination of the program’s progression from protecting kidney function through restoring it to supporting active tissue renewal. Research published in Cell Stem Cell (Humphreys, B.D., et al., 2008, “Intrinsic epithelial cells repair the kidney after injury,” doi:10.1016/j.stem.2008.01.014) examined endogenous kidney epithelial cell repair mechanisms and the role of stem cell-mediated tissue renewal in kidney injury recovery in adult subjects. The study was conducted independently and was not affiliated with Blue Heron Health News.
Supporting Science: Gut Microbiome and Systemic Disease. The program’s foundational framework is built on the established scientific understanding that gut microbiome dysbiosis contributes to immune system dysregulation, systemic inflammation, and the progression of systemic diseases including CKD, diabetes, and cardiovascular disease. A comprehensive review published in Nature Reviews Nephrology (Anders, H.J., et al., 2013, “The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease,” doi:10.1038/nrneph.2013.113) examined the relationship between intestinal microbiota composition, intestinal barrier permeability, immune dysregulation, and kidney disease progression in adult subjects. The study was conducted independently and was not affiliated with Blue Heron Health News.
Supporting Science: Dietary Intervention and CKD Progression. The dietary modification framework underlying all three program phases is grounded in peer-reviewed evidence on the role of specific food choices in modulating gut microbiome composition, systemic inflammation, and kidney function in CKD patients. Research published in the Journal of Renal Nutrition (Kalantar-Zadeh, K., et al., 2017, “Nutritional management of chronic kidney disease,” doi:10.1053/j.jrn.2017.01.001) examined the role of dietary composition — including macronutrient quality, plant-based food intake, and microbiome-supportive eating patterns — in CKD progression and kidney function outcomes in adult subjects. The study was conducted independently and was not affiliated with Blue Heron Health News.
Market Context
The following market data is provided as independent industry context for the chronic kidney disease management and digital health program categories in which this product operates. The figures cited are sourced from third-party market research firms and are not claims made by Blue Heron Health News regarding its own commercial performance.
The global chronic kidney disease treatment market was valued at approximately $12.6 billion in 2024 and is projected to reach $22.3 billion by 2033, at a compound annual growth rate of 6.6 percent, according to Precedence Research (Chronic Kidney Disease Treatment Market Size, Share & Trends Report 2033, Precedence Research, 2025; precedenceresearch.com). Growing consumer interest in non-pharmacological lifestyle interventions for CKD management has been identified as an emerging sub-segment alongside conventional pharmaceutical treatments.
The global digital health market was valued at approximately $233.0 billion in 2024 and is projected to reach $1,033.5 billion by 2034, at a compound annual growth rate of 16.0 percent, according to Precedence Research (Digital Health Market Size, Share & Trends Report 2034, Precedence Research, 2025; precedenceresearch.com). Digital health programs covering lifestyle-based management of chronic conditions including kidney disease represent one of the fastest-growing sub-segments within the category.
The global gut health market was valued at approximately $49.4 billion in 2024 and is projected to reach $103.3 billion by 2033, at a compound annual growth rate of 8.6 percent, according to Precedence Research (Gut Health Market Size, Share & Trends Report 2033, Precedence Research, 2025; precedenceresearch.com). Growing scientific recognition of the gut-kidney axis and the gut microbiome’s role in systemic disease management has driven increased consumer interest in gut-health-focused interventions for chronic conditions.
According to the National Kidney Foundation (NKF Kidney Disease Facts 2024, National Kidney Foundation, 2024; kidney.org), chronic kidney disease affects approximately 37 million adults in the United States — representing about 15 percent of the adult U.S. population — and an estimated 90 percent of individuals with CKD are unaware of their condition until it has progressed significantly. The NKF identifies lifestyle modification, including dietary intervention, as a primary strategy for slowing CKD progression in affected individuals.
Availability and Purchasing
The Chronic Kidney Disease Solution is available through Blue Heron Health News’s authorized retail portal at blueheronhealthnews.com. The program is priced at $49 and is a one-time charge with no subscription, renewal, or recurring costs. All purchases include lifetime access to the digital PDF/e-book version, unlimited downloads for the purchaser and immediate family, and all future updates at no additional charge. An optional physical printed book edition is available at cost of printing only following digital purchase.
All purchases are processed through ClickBank and are subject to a 60-day no-questions-asked money-back guarantee. Product support is available through the Blue Heron Health News contact portal. Order support is available directly through ClickBank at clkbank.com.
Quality and Publishing Standards
The Chronic Kidney Disease Solution is authored by Shelly Manning and published by Blue Heron Health News. The program content is grounded in peer-reviewed research on the gut-kidney axis, gut microbiome dysbiosis, dietary intervention in CKD, and kidney tissue repair mechanisms. The program is formatted as a clear, structured, and practical digital guide designed to be accessible to non-specialist adult readers.
Transactions are processed through ClickBank (Click Sales, Inc., a Delaware corporation), a registered e-commerce retailer. ClickBank’s role as retailer does not constitute an endorsement, approval, or review of the program or any claims, statements, or opinions used in its promotion. The program’s content is based on the author’s opinion and is provided on an as-is basis.
Usage Guidance
The Chronic Kidney Disease Solution is intended for adult use as a self-directed digital health and lifestyle program. The author advises that readers continue working with their healthcare provider throughout the program, particularly individuals managing CKD alongside diabetes, high blood pressure, cardiovascular disease, or other underlying conditions, and those taking prescription medications. The program is designed to complement, not replace, professional medical care. Individual responses to lifestyle interventions may vary.
The Chronic Kidney Disease Solution is a digital lifestyle and health education program. It is not a medical device, pharmaceutical product, or dietary supplement. The program is not intended to diagnose, treat, cure, or prevent any disease. The scientific citations included in this press release describe independent research on the gut-kidney axis, gut microbiome health, dietary intervention in CKD, and kidney tissue repair mechanisms conducted under conditions unaffiliated with Blue Heron Health News. They do not constitute clinical evidence that this program produces equivalent outcomes to those described in the cited studies, and no such equivalence is claimed by the author or publisher. Readers are encouraged to consult a qualified healthcare professional before making any changes to their diet, lifestyle, or supplementation regimen. Individual results may vary.
Affiliate Disclosure: This press release may contain links to retail partner websites through which the distributor may receive compensation if a purchase is made following a referral. This disclosure is made in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The existence of this affiliate relationship does not influence the factual content of this press release.
About Blue Heron Health News
Blue Heron Health News is a digital health publishing company distributing evidence-informed wellness programs authored by health professionals and experienced practitioners. The Chronic Kidney Disease Solution is a three-phase digital program authored by Shelly Manning covering gut microbiome restoration, dietary modification, and kidney tissue support for adults managing chronic kidney disease. The program is distributed via ClickBank with a 60-day satisfaction guarantee and lifetime digital access. For more information, visit blueheronhealthnews.com.
Media Contact
Shelly Manning
Author, The Chronic Kidney Disease Solution
Blue Heron Health News
support@blueheronhealthnews.com
Multimedia Assets
- Product Cover Image: blueheronhealthnews.com/health/wp-content/uploads/2020/04/The-Chronic-Kidney-Disease-Solution-500px.jpg
- Publisher Logo: blueheronhealthnews.com/health/wp-content/uploads/2015/09/logo_long.jpg
- Money-Back Guarantee Badge: blueheronhealthnews.com/health/wp-content/uploads/2020/01/MoneyBack100-150×150-1.png
Author: Shelly Manning, Blue Heron Health News — @BlueHeronHealth
Company: @BlueHeronHealth
Distributed By: XPR Media — @XPR_Syndicate
The post The Chronic Kidney Disease Solution Reviews: Three-Phase Natural CKD Program Book by Shelly Manning Enters Commercial Market appeared first on 24 Health Times.
